An experimental medication that targets a protein in Ebola virus called VP24 protected 75 percent of a group of monkeys that were studied from Ebola virus infection, according to new research.
An experimental medication that targets a protein in Ebola virus called VP24 protected 75 percent of a group of monkeys that were studied from Ebola virus infection, according to new research.